Surviving Mesothelioma is quite possible as so many people have done so. Although Mesothelioma is a very rare cancer, there are three different treatment plans patients can opt to try. The three plans are different from one another and patients have the opportunity to try each one. In fact, patients can use a combination of the different treatment plans. This, of course, has to be supervised by their doctor. The three different treatment plans are standard therapies, clinical trials and alternative modalities. Below, is a closer look at each plan and what it entails.
The Difference Between Standard Therapies and Clinical Trials
Standard therapies refers to chemotherapy, surgery and radiation. Clinical trials are more like experiments performed while still doing research on a particular drug or procedure. Clinical trials are done to see if a new drug or procedure is safer and better than an already existing one. Approval for such trials must be approved by the health authority and ethics committee. This is usually a last option for patients diagnosed with Mesothelioma. They typically turn to clinical trials if standard therapies did not work properly or effectively.
What Alternative Modalities Refer To
Alternative Modalities simply means holistic medicine. This practice puts more emphasis on the body’s immune system to rid the body of the cancer cells or to stop them from growing and spreading to different parts of the body. This is believed to be done by vitamin therapy, herbs, dietary therapy, cannabis oil, detoxification and so much more. As stated above, a patient does not have to choose one treatment plan. They can decide to undergo chemotherapy and still take vitamins or alter their diet. A different combination of the treatment plans can be implemented for the benefit of the patient’s overall health. Again, everything is monitored by a doctor, and he or she can make recommendations to the patient in question.
Mesothelioma is a rare cancer that affects people worldwide. However, just because it is rare, does not mean that there is not enough information available on it. Many people diagnosed with it have survived well beyond what was expected.